Követés
Albrecht Stenzinger, MD
Albrecht Stenzinger, MD
Institute of Pathology, University Hospital Heidelberg, Germany
E-mail megerősítve itt: med.uni-heidelberg.de
Cím
Hivatkozott rá
Hivatkozott rá
Év
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
TA Chan, M Yarchoan, E Jaffee, C Swanton, SA Quezada, A Stenzinger, ...
Annals of Oncology 30 (1), 44-56, 2019
11732019
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
10262013
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
5992012
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ...
Annals of Oncology 31 (11), 1491-1505, 2020
3672020
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ...
Nature Metabolism 3 (2), 149-165, 2021
2752021
Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach
S Wienert, D Heim, K Saeger, A Stenzinger, M Beil, P Hufnagl, M Dietel, ...
Scientific reports 2 (1), 1-7, 2012
2622012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ...
Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012
2322012
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
2052015
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends …
DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ...
Journal for immunotherapy of cancer 8 (1), 2020
1952020
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ...
British journal of cancer 109 (10), 2665-2674, 2013
1882013
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ...
Nature medicine 22 (3), 278-287, 2016
1802016
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
N Ertych, A Stolz, A Stenzinger, W Weichert, S Kaulfuß, P Burfeind, ...
Nature cell biology 16 (8), 779-791, 2014
1782014
Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment
P Schelb, S Kohl, JP Radtke, M Wiesenfarth, P Kickingereder, ...
Radiology 293 (3), 607-617, 2019
1682019
Integrative genomic and transcriptomic analysis of leiomyosarcoma
P Chudasama, SS Mughal, MA Sanders, D Hübschmann, I Chung, ...
Nature communications 9 (1), 1-15, 2018
1632018
Tumor mutational burden as a predictive biomarker in solid tumors
D Sha, Z Jin, J Budczies, K Kluck, A Stenzinger, FA Sinicrope
Cancer discovery 10 (12), 1808-1825, 2020
1542020
A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
AL Volckmar, H Sültmann, A Riediger, T Fioretos, P Schirmacher, ...
Genes, Chromosomes and Cancer 57 (3), 123-139, 2018
1422018
Tumor mutational burden standardization initiatives: recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment …
A Stenzinger, JD Allen, J Maas, MD Stewart, DM Merino, MM Wempe, ...
Genes, Chromosomes and Cancer 58 (8), 578-588, 2019
1392019
NRG1 Fusions in KRAS Wild-Type Pancreatic CancerNRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter, M Fröhlich, ...
Cancer discovery 8 (9), 1087-1095, 2018
1382018
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
A Warth, J Cortis, A Soltermann, M Meister, J Budczies, A Stenzinger, ...
British journal of cancer 111 (6), 1222-1229, 2014
1302014
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
M Jesinghaus, B Konukiewitz, G Keller, M Kloor, K Steiger, M Reiche, ...
Modern Pathology 30 (4), 610-619, 2017
1252017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20